Eli Lilly Is Finally Cheap, Warranting An Upgrade To Buy Seeking Alpha Eli Lilly Is Finally Cheap, Warranting An Upgrade To Buy. Eli Lilly (LLY) 6 hours
Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Trading Range Seeking Alpha 11 hours
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today The Motley Fool 21 hours
Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In Insider Monkey 3 days
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly’s Weight-Loss Treatments The Motley Fool 3 days
This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk’s and Eli Lilly’s Weight Loss Treatments The Motley Fool 3 days
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough CNBC 5 days
World’s Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna Yahoo Finance 7 days
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now Yahoo Finance 1 week
Roche stock is falling after report its Wegovy challenger is causing patients to vomit Fortune 1 week
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes, Alzheimer’s drugs CNBC 1 week
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I’m Not Talking About Zepbound) The Motley Fool 1 week
Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly The Motley Fool 2 weeks
Jim Cramer Says Eli Lilly and Company (LLY) Has the Biggest Pharmaceutical Potential Insider Monkey 2 weeks
Does Eli Lilly and Company (LLY)’s Financial Performance Make It A Safe Stock To Invest In Now? Insider Monkey 2 weeks
This Big Move by Eli Lilly May Solve the Weight Loss Drug Market’s Biggest Problem Yahoo Finance 2 weeks
Eli Lilly and Company (LLY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) Seeking Alpha 2 weeks
Eli Lilly Just Made Zepbound Even More Appealing. Here’s What Smart Investors Need to Know. The Motley Fool 2 weeks
How Lilly, Novo Could Beat Tesla To The Trillion-Dollar Club; Plus, Nvidia’s Battle With Microsoft, Apple Investor's Business Daily 2 weeks
Eli Lilly Trades Near All-Time High: Check Out The IBD 50, Big Cap 20, Other Top Stock Lists Investor's Business Daily 3 weeks
Novo Nordisk’s Ozempic Shortage Is Worsening. It’s Good News For Eli Lilly Stock. Yahoo Finance 3 weeks